tiprankstipranks
Advertisement
Advertisement
KPTI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsKPTI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
13d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
18d ago
GoDaddy, NXT, Karyopharm, AXT, Enbridge Trending With Analysts
Premium
Weekend Updates
GoDaddy, NXT, Karyopharm, AXT, Enbridge Trending With Analysts
23d ago
Karyopharm downgraded to Neutral from Outperform at Baird
PremiumThe FlyKaryopharm downgraded to Neutral from Outperform at Baird
24d ago
Karyopharm down 69% after XPORT-EC-042 trial did not meet primary endpoint
Premium
The Fly
Karyopharm down 69% after XPORT-EC-042 trial did not meet primary endpoint
24d ago
Karyopharm to submit sNDA for selinexor plus ruxolitinib
Premium
The Fly
Karyopharm to submit sNDA for selinexor plus ruxolitinib
24d ago
Karyopharm sinks after revealing executive cash retention program
PremiumThe FlyKaryopharm sinks after revealing executive cash retention program
1M ago
RBC says Karyopharm weakness after compensation plan a buying opportunity
Premium
The Fly
RBC says Karyopharm weakness after compensation plan a buying opportunity
1M ago
Karyopharm Launches 2026 Executive Retention Incentive Program
Premium
Company Announcements
Karyopharm Launches 2026 Executive Retention Incentive Program
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100